World Intravenous (IV) Ibuprofen Market Size and Share

World Intravenous
(IV) IbuprofenMarket
Opportunities and
Forecasts,
2015 – 2022

Introductionof IntravenousIbuprofonMarket
Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat
pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute
illness. The intravenous (IV) route for ibuprofen administration has a faster onset of action as
compared to the other routes. IV ibuprofen is preferred for the management of post-operative and
acute pain. The demand for ibuprofen has increased due to the side effects of opioid analgesics
such as respiratory depression, allergic reactions, sedation, and gastrointestinal events.
The market for IV ibuprofen for pain management is in its nascent stage. The world IV ibuprofen
market was valued at $3.6 million in 2015, and is projected to reach $14.2 million by 2022,
registering a CAGR of 20% during the forecast period. Advantages associated with IV ibuprofen
such as rapid result and targeted drug delivery have resulted in the growth of this market. In 2015,
FDA approved IV ibuprofen for pediatric use, due to which the market is expected to register a
significant growth during the forecast period. Other factors that affect the market growth
significantly include increasing incidence of cancer, cardiovascular ailments, pain, headache,
toothache, back pain, arthritis, trauma, and shifting trend towards the use of non-opioids drugs.
Factors that would hamper the market growth include side effects associated with IV ibuprofen and
lengthy approval process.

Introduction
Scope of
the Report
Key Benefits
Key Audiences

KeyBenefits
Introduction toSmart Syringes Market
✓ This report provides an extensive analysis of the current and emerging trends
Synthetic biology is aand novel dynamics area ofinresearch the worldthat IV Ibuprofen is the amalgamation market. of multiple disciplines such
as molecular biology, biotechnology, biophysics and genetic engineering among others. There are
chiefly two approaches ✓ The used world inIV synthetic Ibuprofenbiology market namely, is analyzed top based down approach on countries andsuch bottom as the up
approach. Top-down approach U.S., Australia, involves Canada the re-design and Southand Korea. fabrication of existing biological systems
for producing synthetic products. Bottom-up approach involves designing and construction of de
novo biological systems ✓ Theorstudy devices evaluating that do not competitive exist in nature. landscape has been taken into account to
understand the competitive environment across the countries considered.
World synthetic biology market was valued at $ 5,245.7 million in 2015, growing at a CAGR of 23%
during the forecast ✓period. This report Assistance provides fromdetailed government quantitative and private analysis organizations, of the current risingmarket number and of
synthetic biology research estimations entitiesfrom and 2015 declining to 2022, cost ofwhich DNA sequencing assists to identify & synthesizing prevailing are the
major factors drivingopportunities.
the market growth. On the contrary, bio-safety & bio-security issues, would
hinder the market growth. The issues related to the misuse of synthetic biology or possibilities of
accidental release✓ ofExhaustive pathogens analysis into free of atmosphere the world IV would Ibuprofen remainmarket as a key by challenge indication worldwide. describes
However, rising demand the types for bio-fuels, of indications growing that awareness will gain prominence emerging future. economies and rising R&D
investments for synthetic drugs and vaccines would offer lucrative opportunities in the market

Table ofContents:
1. Introduction
2. Executive Summary
3. Market Overview
4. World Intravenous Ibuprofen market, By Age Group, 2015-2022
5. World Intravenous Ibuprofen Market, By Indication, 2015-2022
6. World Intravenous Ibuprofen Market, By Country, 2015-2022
7. Company Profiles
Enquiry about report at: https://www.alliedmarketresearch.com/purchase-enquiry/1387

World Intravenous Ibuprofen – MarketBy
Segments
KEY MARKET
SEGMENTS
MARKET BY
INDICATIONS
MARKET BY
AGE GROUP
MARKET BY
GEOGRAPHY

Intravenous Introduction Ibuprofen toSmart MarketKey Syringes Market
Synthetic biology is a novel area of research that is the amalgamation of multiple disciplines such
as molecular biology, biotechnology, biophysics and genetic engineering among others. There are
chiefly two approaches used in synthetic biology namely, top down approach and bottom up
approach. Top-down approach involves the re-design and fabrication of existing biological systems
for producing synthetic products. Bottom-up approach
Pain/Inflammatory
involves designing and construction of de
novo biological systems or devices that do not exist in nature.
By Indications
World synthetic biology market was valued at $ 5,245.7 million in 2015, growing at a CAGR of 23%
during the forecast period. Assistance from government and private organizations, rising number of
synthetic biology research entities and declining cost of DNA sequencing & synthesizing are the
major factors driving the market growth. On the contrary,
Fever
bio-safety & bio-security issues, would
hinder the market growth. The issues related to the misuse of synthetic biology or possibilities of
accidental release of pathogens into free atmosphere would remain as a key challenge worldwide.
However, rising demand for bio-fuels, growing awareness in emerging economies and rising R&D
investments for synthetic drugs and vaccines would offer lucrative opportunities in the market

Intravenous Introduction Ibuprofen toSmart MarketKey Syringes Market
Synthetic biology is a novel area of research that is the amalgamation of multiple disciplines such
as molecular biology, biotechnology, biophysics and genetic engineering among others. There are
chiefly two approaches used in synthetic biology namely, top down approach and bottom up
approach. Top-down approach involves the re-design and fabrication of existing biological systems
for producing synthetic products. Bottom-up approach
Pediatrics
involves designing and construction of de
novo biological systems or devices that do not exist in nature.
By AgeGroups
World synthetic biology market was valued at $ 5,245.7 million in 2015, growing at a CAGR of 23%
during the forecast period. Assistance from government and private organizations, rising number of
synthetic biology research entities and declining cost of DNA sequencing & synthesizing are the
major factors driving the market growth. On the contrary,
Adults
bio-safety & bio-security issues, would
hinder the market growth. The issues related to the misuse of synthetic biology or possibilities of
accidental release of pathogens into free atmosphere would remain as a key challenge worldwide.
However, rising demand for bio-fuels, growing awareness in emerging economies and rising R&D
investments for synthetic drugs and vaccines would offer lucrative opportunities in the market

Company Profiles
1. Cumberland Pharmaceuticals Inc.
2. Alveda Pharmaceuticals, Inc.
3. CSL Limited, Sandor Medicaids Pvt Ltd.
4. PT. Soho Industri Pharmasi
5. Germin MED, Grifols S.A.
6. Harbin Gloria Pharmaceuticals Co., Ltd.
7. Al Nabeel International Ltd.
8. Laboratorios Valmorca, C.A.

Thank You!
For More Details
Visit us at
https://www.alliedmarketresearch.com/intravenousibuprofen-market
Follow Us On